MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (indian pharma)
- BIOCON
BIOCON Share Price (BICN)
Here is the latest stock price and chart of Biocon Ltd. For more details, see the Biocon Ltd company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Covid-19 Special 3x Opportunity: Five "Essential" Stocks to Buy Before the Lockdown Ends...
| Live BSE Quotes | Jun 5, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)389.60 | Open (Rs) 398.00 | High (Rs) 400.35 | Low (Rs) 388.65 |
| % Change-1.03 | Volume 186,363 | Value (Rs) 73,467,161 | 52-Week H/L 400.35 / 211.30 |
| Live NSE Quotes | Jun 5, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)389.60 | Open (Rs) 397.00 | High (Rs) 400.50 | Low (Rs) 388.60 |
| % Change-1.03 | Volume 5,323,724 | Value (Rs) 2,098,891,085 | 52-Week H/L 400.50 / 211.05 |
| Change | |||||
|---|---|---|---|---|---|
| 1 Day -1.03% | 1 Month 11.41% | 3 Months 24.55% | 1 Year 42.94% | 5 Years (CAGR)* 39.39% | 10 Years (CAGR)* 23.28% |
* Compound Annual Growth Rate
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 13.10 | P/E Ratio (x) 29.73 | Market Cap (Rs m) 233,760.00 | P/BV (x) 3.83 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
BIOCON Share Price Today:
BIOCON last traded price was down 1.0% to Rs 389.6 on the BSE. On the NSE, BIOCON last traded price was down 1.0% to Rs 389.6. The total volume of shares traded was 5.5 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.4%. And the benchmark S&P BSE SENSEX was at 34,287.2 (up 0.9%).
Over the last 30 days, the BIOCON share price is up 11.4%. And over the last one year, BIOCON share price is up 42.9%.
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- BSE A Group Gainers Today
- NSE Above Rs 20 Gainers Today
- BSE Above Rs 20 Gainers Today
- BSE Sensex Gainers Today
- BSE Small Cap Gainers Today
- BSE 500 Gainers Today
- BSE A Group Losers Today
- Most Active Stocks Rs 1 to 2
- NSE Above Rs 20 Losers Today
- ANALYSE:
- TCS
- HDFC BANK
- ITC LIMITED
- ONGC
- HINDUSTAN UNILEVER
- SBI
Today's Market
Sensex Ends 307 Points Higher; Metal and Telecom Stocks Witness Buying(Closing)
Indian share markets traded on a positive note throughout the day and ended higher, tracking positive global sentiments.
Related Views On News
BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)
Jan 24, 2020 | Updated on Jan 24, 2020For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)
Nov 1, 2019 | Updated on Nov 1, 2019For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
More Views on NewsMost Popular
6 Charts Showing the State of Indian Financial Markets in 2020 (Sector Info)
May 26, 2020Six charts showing how Indian financial markets have performed in 2020 so far...
Why We Picked This Smallcap Stock for a Post Coronavirus World (Profit Hunter)
May 28, 2020Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.
What the RBI's Rate Cut Means for Options Traders (Fast Profits Daily)
May 25, 2020The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.
Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade? (Profit Hunter)
May 25, 2020Will the mutlibagger blue chips of the past decade continue to rule the bourses?
MoreOUR TOP 5 IDEAS
- How to Trade the Coronavirus Crash - Download this FREE Report Now
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
TRACK BIOCON
- Track your investment in BIOCON with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON BIOCON
BIOCON 5-YR ANALYSIS
COMPARE BIOCON WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.